Bridgehead Communications

BioSure

Self-test IVD manufacturer

Diagnostics & imagingPatient access & engagement

Essex-based manufacturer of CE-marked self-test IVDs, best known for producing the world's first CE-marked HIV self-test, sold through UK pharmacies and the NHS.

The read

BioSure develops and manufactures self-test in-vitro diagnostics, most notably the BioSure HIV Self Test, the first CE-marked HIV self-test on the market, alongside a wider range of self-test kits distributed through NHS sexual-health services and retail pharmacy.

Its distribution model, sold both online and through Boots UK stores, positions it toward consumer self-testing rather than lab-based diagnostics, giving it a more retail-facing route to patients than most diagnostics vendors in this index.

The Bridgehead view

BioSure's retail-pharmacy distribution through Boots is a genuinely different go-to-market from the NHS-procurement-led diagnostics story that dominates this sector, worth telling as a consumer-health narrative rather than a clinical-procurement one.

Work with us

Building a medtech brand?

We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.

Working across the healthcare sector?

We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.

The firm that knows medtech

We map this sector because
we represent it.

Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.